Mark Johnson to Infant
This is a "connection" page, showing publications Mark Johnson has written about Infant.
Connection Strength
0.126
-
Rispens JR, Jones SA, Clemmons NS, Ahmed S, Harduar-Morano L, Johnson MD, Edge C, Vyas A, Bourgikos E, Orr MF. Anhydrous Ammonia Chemical Release - Lake County, Illinois, April 2019. MMWR Morb Mortal Wkly Rep. 2020 Jan 31; 69(4):109-113.
Score: 0.030
-
Ashley DP, Fraser J, Yun H, Kunz A, Fairchok M, Tribble D, Mitra I, Johnson MD, Hickey PW, Ganesan A, Deiss RG, Lalani T. A Comparison of Pretravel Health Care, Travel-Related Exposures, and Illnesses among Pediatric and Adult U.S. Military Beneficiaries. Am J Trop Med Hyg. 2019 05; 100(5):1285-1289.
Score: 0.029
-
Ramkissoon SH, Bi WL, Schumacher SE, Ramkissoon LA, Haidar S, Knoff D, Dubuc A, Brown L, Burns M, Cryan JB, Abedalthagafi M, Kang YJ, Schultz N, Reardon DA, Lee EQ, Rinne ML, Norden AD, Nayak L, Ruland S, Doherty LM, LaFrankie DC, Horvath M, Aizer AA, Russo A, Arvold ND, Claus EB, Al-Mefty O, Johnson MD, Golby AJ, Dunn IF, Chiocca EA, Trippa L, Santagata S, Folkerth RD, Kantoff P, Rollins BJ, Lindeman NI, Wen PY, Ligon AH, Beroukhim R, Alexander BM, Ligon KL. Clinical implementation of integrated whole-genome copy number and mutation profiling for glioblastoma. Neuro Oncol. 2015 Oct; 17(10):1344-55.
Score: 0.022
-
Johnson MD, Gray ME, Pepinsky RB, Stahlman MT. Lipocortin-1 immunoreactivity in the human pituitary gland. J Histochem Cytochem. 1990 Dec; 38(12):1841-5.
Score: 0.016
-
Johnson MD, Kamso-Pratt JM, Whetsell WO, Pepinsky RB. Lipocortin-1 immunoreactivity in the normal human central nervous system and lesions with astrocytosis. Am J Clin Pathol. 1989 Oct; 92(4):424-9.
Score: 0.015
-
Johnson MD, Jacobs AH. Congenital smooth muscle hamartoma. A report of six cases and a review of the literature. Arch Dermatol. 1989 Jun; 125(6):820-2.
Score: 0.014